![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 21, 2017 10:29:33 AM
(and we have lots of evidence of that here) AND you
provide it with every post.
In your post you said:
I wanted to say just one more thing regarding management because this subject keeps coming up. I think that at this point in time continuity is more important than starting a revolution in the upper echelons of Pluristem. Mr Aberman and Mr Yani appear to have been working together for a very long time. They may not have a scientific background themselves, but I imagine that as CEOs they are well supported by their scientific staff.
don't seem to understand this!
You have two very successful and talented managers at the top,
AND they have the support of the scientific brainpower not only
inside the company, but many pioneers and
thought leader in the MSC field (clinicians, academic researcher, etc.)
I wont repeat my rationale for continuing to buy (a number of
very reasonable and articulate people have done that in the
last few weeks), but I can tell you that the "EichSho-LMFAO" twins
and their cousin 999 whining about management is of very
little impact (ah, ZERO!!!!, or less).
Anyway, Merry Christmas and enjoy your holiday,
zzaatt.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM